“Efficacy and Safety of Evobrutinib in Relapsing Multiple Sclerosis: A Systematic Review of Randomized Controlled Trials”, magna-neurologica, vol. 3, no. 2, pp. 138–149, Jul. 2025, doi: 10.20961/magnaneurologica.v3i2.1929.